会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明授权
    • 1,7-annelated indolecarboxylic acid esters and amides
    • 1,7-芳族吲哚羧酸酯和酰胺
    • US5198437A
    • 1993-03-30
    • US628109
    • 1990-12-17
    • Derk HammingaHans H. HaeckIneke Van WijngaardenWouter Wouters
    • Derk HammingaHans H. HaeckIneke Van WijngaardenWouter Wouters
    • C07D519/00
    • C07D519/00
    • 1,7-Annelated esters and amides of indolecarboxylic acids having formula 2, ##STR1## wherein R.sub.1 is halogen;n has a value of 0-2;Z together with the carbon atom, the nitrogen atom and the intermediate carbon atom, forms a heterocyclic group consisting of 6 ring atoms in which, besides the nitrogen atom already present, a second hetero atom of S is present, which ring may be annelated with a benzene ring;R.sub.3 is hydrogen, halogen, alkyl, alkoxy or alkylthio having 1-4 carbon atoms; andR.sub.2 is a group --CO--Y--R.sub.7 wherein Y is an oxygen atom, or a group --NR.sub.6, wherein R.sub.6 is hydrogen or alkyl having 1-3 C-atoms, and R.sub.7 represents a group of the formula ##STR2## wherein p has the value 1 or 2, q has the value 2 or 3, R.sub.8 is hydrogen or alkyl or hydroxyalkyl having 1 or 2 C-atoms, r is 0 or 1, and R.sub.10 is absent. The compounds and their salts are very strong selective antagonists of neuronal 5-hydroxytryptamine (5-HT) receptors, and can be used for the treatment of symptoms which are caused by over-stimulation of those receptors.
    • 具有式2的吲哚羧酸的1,7-苯基化酯和酰胺,其中R1是卤素; n的值为0-2; Z与碳原子,氮原子和中间碳原子一起形成由6个环原子组成的杂环基,其中除了存在的氮原子之外,还存在S的第二杂原子,该环可以与 苯环; R3是氢,卤素,烷基,烷氧基或具有1-4个碳原子的烷硫基; R2为-CO-Y-R7基团,其中Y为氧原子,或-NR6基团,其中R6为氢或具有1-3个C原子的烷基,R7为下式基团其中 p的值为1或2,q为2或3,R8为氢或具有1或2个C原子的烷基或羟烷基,r为0或1,R10不存在。 化合物及其盐是神经元5-羟色胺(5-HT)受体非常强的选择性拮抗剂,可用于治疗由这些受体的过度刺激引起的症状。
    • 4. 发明授权
    • Substituted 3,4-annelated benzimidazol-2(1H)-ones
    • 取代的3,4-苯并苯并咪唑-2(1H) - 酮
    • US5183822A
    • 1993-02-02
    • US631957
    • 1990-12-21
    • Ineke Van WijngaardenDerk HammingaWouter Wouters
    • Ineke Van WijngaardenDerk HammingaWouter Wouters
    • C07D487/06A61K31/415A61K31/47A61K31/55A61P43/00C07D451/04C07D451/12C07D451/14C07D453/02C07D453/06C07D471/06C07D498/06C07D513/06C07D519/00
    • C07D519/00
    • The present invention is concerned with compounds of formula 1 ##STR1## wherein R.sub.0 is alkyl, alkoxy or alkylthio having 1-4 carbon atoms, hydroxy, halogen,Z, together with the carbon atom and the nitrogen atom and the intermediate carbon atom, constitutes a heterocyclic group which consists of 5-8 ring atoms, in which, besides the already present nitrogen atom, a second hetero atom from the group N, O, or S may be present, which ring may be substituted with 1-4 methyl group, or which ring may be annelated with a phenyl group optionally substituted with fluorine, or a methyl or methoxy group;A is a group of formula 2 or 3 ##STR2## wherein one of the groups R.sub.3, R.sub.4 and R.sub.5 is hydrogen, alkyl having 1-6 carbon atoms, cycloalkyl having 3-7 carbon atoms, alkenyl having 2-6 carbon atoms or phenyl alkyl having 1-3 carbon atoms in the alkyl group, and the two other groups independently of each other are hydrogen or alkyl having 1-4 carbon atoms, or wherein A is a polycyclic ring system in which one carbon atom is replaced by a tertiary nitrogen atom, for example, a ring system of formula 4, 5 or 6, ##STR3## wherein p is an integer having the value 1 or 2, q is an integer having the value 2, 3 or 4, r is an integer having the value 1, 2 or 3, and R.sub.6 is alkyl having 1-4 carbon atoms, cycloalkyl having 3-6 carbon atoms, cyclopropylmethyl, allyl, propargyl or benzyl, andB is an oxygen atom or a group .dbd.N--R, wherein R is hydrogen, alkyl having 1-6 carbon atoms or benzyl, or whereinB-A represents a group of formula 7 ##STR4## wherein R.sub.3 and R.sub.5 having the meanings defined above, and the pharmaceutically acceptable acid addition salts thereof, which are pharmaceutically active as 5-HT receptor antagonists, and pharmaceutical products containing these compounds.
    • 7. 发明授权
    • Spasmolytically active tertiary amine derivatives
    • 分解活性的叔胺衍生物
    • US4889849A
    • 1989-12-26
    • US294997
    • 1989-01-09
    • Ineke Van WijngaardenJohannes M. A. ZwagemakersJan Van Dijk
    • Ineke Van WijngaardenJohannes M. A. ZwagemakersJan Van Dijk
    • C07D211/46A61K31/445A61K31/4468A61K31/451A61K31/455C07D211/32C07D211/58C07D211/62C07D295/18C07D295/194
    • C07D295/194C07D211/32C07D211/58
    • The invention relates to new spasmolytically active tertiary amine derivatives and the salts thereof, of the formula (1) ##STR1## wherein the symbols have the following meanings: .circle.A is phenyl, or a 5- or 6-membered aromatic group containing 1 or 2 of the following hetero atoms: oxygen and/or sulphur and/or nitrogen;R.sub.1 and R.sub.2 may be equal or different and are hydrogen or substituents;R.sub.3 is a hydrogen atom or, together with R.sub.4, may form a ring consisting of 6 or 7 carbon atoms;R.sub.4 is a hydrogen atom or alkyl group having 1-3 carbon atoms;R.sub.5 is a straight, branched or cyclic alkyl group having 1-4 carbon atoms;R.sub.6 is a straight or branched, saturated or unsaturated alkylene group having a chain length of 2-6 carbon atoms;Z is the group NR.sub.12, wherein R.sub.12 is a hydrogen atom or an alkyl group having 1-3 carbon atoms, or Z is an oxygen atom;n has the value 0 or 1;X is a carbonyl group, thiocarbonyl group or SO.sub.2 group;R.sub.7 and R.sub.8, together with the nitrogen atom to which they are bound, constitute a fully or partly saturated heterocyclic ring consisting of 5-8 ring atoms and which may comprise in addition an O, N or S-atom as the second hetero atom, and may be substituted.
    • 本发明涉及式(1)的新的解压活性叔胺衍生物及其盐,其中符号具有以下含义:& A是苯基或5-或6-元芳基 含有1或2个以下杂原子:氧和/或硫和/或氮; R 1和R 2可以相同或不同,为氢或取代基; R3是氢原子,或者与R4一起可以形成由6或7个碳原子组成的环; R4是氢原子或具有1-3个碳原子的烷基; R5是具有1-4个碳原子的直链,支链或环状烷基; R6是链长2-6个碳原子的直链或支链饱和或不饱和亚烷基; Z是NR12基团,其中R12是氢原子或具有1-3个碳原子的烷基,或Z是氧原子; n的值为0或1; X是羰基,硫代羰基或SO2基团; R7和R8与它们所结合的氮原子一起构成由5-8个环原子组成的完全或部分饱和的杂环,并且另外可以包含作为第二杂原子的O,N或S-原子, 并且可以被替代。